中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
12期
71-72
,共2页
难治性产后出血%介入治疗%临床疗效
難治性產後齣血%介入治療%臨床療效
난치성산후출혈%개입치료%림상료효
Intractable postpartum hemorrhage%Interventional therapy%Clinical curative effect
目的：探讨介入治疗对难治性产后出血的临床疗效及对保留子宫的意义。方法对该院于2010年1月-2014年1月收治的24例难治性产后出血患者，采用改良Seldinger技术经皮股动脉穿刺行子宫动脉插管并造影，观察治疗效果。结果23例止血成功并保留子宫，仅1例介入治疗失败后改行次全子宫切除术，手术成功率95.8%，手术时间(42.7±3.3)min，术后11例患者出现不同程度的臀部、会阴、大腿胀痛及无力现象，无严重术后并发症发生。结论介入治疗用于难治性产后出血的疗效确切，具有手术时间短、术后恢复快、不良反应少的特点，是目前治疗难治性产后出血的首先方案，值得在临床上推广和应用。
目的：探討介入治療對難治性產後齣血的臨床療效及對保留子宮的意義。方法對該院于2010年1月-2014年1月收治的24例難治性產後齣血患者，採用改良Seldinger技術經皮股動脈穿刺行子宮動脈插管併造影，觀察治療效果。結果23例止血成功併保留子宮，僅1例介入治療失敗後改行次全子宮切除術，手術成功率95.8%，手術時間(42.7±3.3)min，術後11例患者齣現不同程度的臀部、會陰、大腿脹痛及無力現象，無嚴重術後併髮癥髮生。結論介入治療用于難治性產後齣血的療效確切，具有手術時間短、術後恢複快、不良反應少的特點，是目前治療難治性產後齣血的首先方案，值得在臨床上推廣和應用。
목적：탐토개입치료대난치성산후출혈적림상료효급대보류자궁적의의。방법대해원우2010년1월-2014년1월수치적24례난치성산후출혈환자，채용개량Seldinger기술경피고동맥천자행자궁동맥삽관병조영，관찰치료효과。결과23례지혈성공병보류자궁，부1례개입치료실패후개행차전자궁절제술，수술성공솔95.8%，수술시간(42.7±3.3)min，술후11례환자출현불동정도적둔부、회음、대퇴창통급무력현상，무엄중술후병발증발생。결론개입치료용우난치성산후출혈적료효학절，구유수술시간단、술후회복쾌、불량반응소적특점，시목전치료난치성산후출혈적수선방안，치득재림상상추엄화응용。
Objective To investigate the clinical effect of interventional treatment of intractable postpartum hemorrhage and its sig-nificance on the retention of the uterus. Methods In our hospital from 2010 january to 2014 january were treated 24 cases of in-tractable postpartum hemorrhage patients using modified Seldinger technique of percutaneous femoral artery puncture for uterine artery catheterization and angiography, observation of therapeutic effect. Results 23 cases of successful hemostasis and preserva-tion of the uterus, and only 1 cases of interventional therapy after failure of diverted subtotal hysterectomy, the operation success rate was 95.8%, the operation time was (42.7±3.3)min, with varying degrees of buttocks, perineum, thighs pain and weakness of 11 patients, no serious postoperative complications. Conclusion The curative effect of interventional therapy for intractable post-partum hemorrhage is exact, short operation time, rapid postoperative recovery, fewer adverse reactions, is currently the treatment of intractable postpartum hemorrhage excellent scheme, worthy of clinical popularization and application.
